Jubay, Jessa Jane D.

HRN: 28-54-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2026
CO-AMOXICLAV 625MG (TAB)
03/22/2026
03/28/2026
PO
625mg
TID
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: